By Bill D’Zio March 25, 2020
SpaceX Crew Dragon on approach Credit NASAPart 2 of the Life in Space with COVID19 we will delve into Crew demo-2 where NASA and SpaceX are planning a launch within two months. There are a lot of pre-launch milestones and activities to cover to ensure a safe flight for the Astronauts. If anything goes wrong, there are lives at stake. Now NASA and SpaceX have to contend with another potential setback, COVID19 pandemic. (Click here for part I)
The agency’s decision would provide lucrative incentives to the drug’s maker, Gilead Sciences, and could keep lower-priced generic versions of the medicine off the market for several years if remdesivir is approved for use, public health advocates say.
Remdesivir Gets Rare Disease Perks From FDA : Shots — Health News Gilead Science’s remdesivir, an antiviral medicine being tested for treatment of COVID-19, would get a seven-year monopoly if approved by the Food and Drug Administration.
Radboudumc and UMC Utrecht will investigate whether health care workers are better protected against the coronavirus after a vaccination against tuberculosis (BCG vaccine). This vaccine does not directly protect against the coronavirus, but provides a boost to the immune system, which may lead to improved protection against the coronavirus and a milder infection.
19 March 2020.
SARS-CoV-2 uses the SARS-CoV receptor ACE2 for host cell entry.
The spike protein of SARS-CoV-2 is primed by TMPRSS2.
Antibodies against SARS-CoV spike may offer some protection against SARS-CoV-2.
The emerging SARS-coronavirus 2 (SARS-CoV-2) threatens public health. Hoffmann and coworkers show that SARS-CoV-2 infection depends on the host cell factors ACE2 and TMPRSS2 and can be blocked by a clinically proven protease inhibitor. These findings might help to establish options for prevention and treatment.
By Bill D’Zio March 24, 2020 (Originally posted on www.westeastspace.com)
WestEastSpace mapped out NASA locations on a map of COVID19 impacted areas of USA from www.usafacts.org as of March 23rd, 2020With the launch window for NASA’s Mars Perseverance rover opening in a little less than four months, there are nearly daily pre-launch milestones to complete the rover pre flight activities at the Kennedy Space Center in Cape Canaveral, Florida. Tight schedules on complex missions usually do not mix well. Now NASA has to contend with another challenge. COVID19.
NASA Leadership Assessing Mission Impacts of Coronavirus
The world has come to a standstill and is in the grasps of the COVID-19. The world stock markets have come crashing down 30% as supply chains and companies attempt to deal with government response and public fear. Airlines and hotels have had to contend with decreased travel and lodging requirements. Logistics is impacted as factories in various countries deal with increased difficulty and requirements to obtain goods. Factories are closed leading to shortages for truckers, material movers, cargo agents, and other occupations directly involved in moving goods. Companies shift to working remotely in an attempt to comply with government guidance in attempts to minimize the impact of the virus. One Mars mission has already been sidelined because of COVID19. NASA also needs to contend with these challenges.
Covid-19 lasted for 17 days in the cabins of cruise ships:
Cruise ships are often settings for outbreaks of infectious diseases because of their closed environment and contact between travelers from many countries.
What is added by this report?
More than 800 cases of laboratory-confirmed COVID-19 cases occurred during outbreaks on three cruise ship voyages, and cases linked to several additional cruises have been reported across the United States. Transmission occurred across multiple voyages from ship to ship by crew members; both crew members and passengers were affected; 10 deaths associated with cruise ships have been reported to date.
The emergence of the novel coronavirus and its associated disease, COVID-19, has led to a global pandemic and a call for individuals, in the name of overall public health and an attempt to prevent national medical systems from being overwhelmed with too many patients at once, to self-isolate, self-quarantine, and practice social distancing. Many of us are confronted, for perhaps the only time in our lives, with an uncertain span of time in solitude.
Although this is the first time we’ve seen this particular phenomenon, social distancing isn’t a new invention. Humans have always had good reasons to withdraw from society, often for the greater good. Among the champions of isolation and social distancing are astronauts and cosmonauts—including the late Al Worden—whose time in space has often been spent in extended periods of cramped loneliness, away from family and friends. They can serve as inspiration in these difficult times.
As a cultural anthropologist, my research focuses on human behavior, particularly types of behavior shared by groups, and it is clear that social distancing is unusual. Human beings are gregarious creatures and we do tend to be found in “corporate bodies,” ranging from small bands of 30 to 50 people all the way up to huge cities filled with millions. In band societies, everyone knows everyone else and there’s generally shared work, shared play, and lots of shared gossip. In larger societies, where we may be surrounded by virtual strangers, celebrities seem to fill in as the people everyone knows, giving us membership in a community where celebrities are “shared points of reference” (Hermes and Kooijmann 2016). I may not know you well, but we can probably talk to each other about Sigourney Weaver and Tom Hanks.
Public leaders & health officials:
The only thing that matters right now is the speed of your response.
As the COVID-19 cases continue to rise globally, the National Medical Products Administration of China has approved the first-ever antiviral medicine called Favilavir. This medicine is said to possibly treat the now-declared pandemic illness.
Over the weekend, Taizhou’s city government announced that Favilavir, which was initially formulated by a Chinese-owned pharmaceutical firm, is the first medicine authorized to stop the widespread of this fatal illness. At present, this drug is being promoted with the label, Avigan.
According to the Ministry of Science and Technology of China, the Favilavir of Hisun Pharmaceutical is among the three drugs that have presented results for hindering COVID-19 (in initial trials) from spreading and further damaging the health of the people worldwide.
Engineers have created a tiny device that can rapidly detect harmful bacteria in blood, allowing health care professionals to pinpoint the cause of potentially deadly infections and fight them with drugs.
The Rutgers coauthored study, led by researchers at Rochester Institute of Technology, is published in the journal ACS Applied Materials & Interfaces.
“The rapid identification of drug-resistant bacteria allows health care providers to prescribe the right drugs, boosting the chances of survival,” said coauthor Ruo-Qian (Roger) Wang, an assistant professor in the Department of Civil and Environmental Engineering in the School of Engineering at Rutgers University-New Brunswick.
